Pinot noir grape products for nonalcoholic fatty liver disease and other uses
Embodiments described herein provide for uses of grape products, such as Chardonnay and Pinot Noir grape products and grape seed flour, for use in promoting a healthy liver, promoting healthy fat content in a liver, for treating or preventing NAFLD, and other embodiments and uses as described herein.
1. A method of treating non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH) in a mammal in need thereof, comprising administering to the mammal an amount of a Pinot Noir grape seed flour effective to treat NAFLD or NASH.
2. The method of claim 1 , wherein the Pinot Noir grape seed flour reduces the amount of fat deposited in the liver.
3. The method of claim 1 , wherein the Pinot Noir grape seed flour is administered in effective amount to treat NAFLD or NASH of about 1 mg to about 15,000 mg.
4. The method of claim 1 , wherein the mammal is a human, companion animal, domestic pet, husbanded animal, or livestock.
5. The method of claim 1 , wherein the method further comprises at least one additional compound.
6. The method of claim 5 , wherein the at least one additional compound is an antioxidant, an anti-cholesterol medication, anti-glycemic compound, or an insulin sensitizer.
7. The method of claim 5 , wherein the at least one additional compound is vitamin E, vitamin A, vitamin C, a carotenoid, lipoic acid, ubiquinol, ubiquinone, or glutathione.